PMCUF
Pro Medicus Limited
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Last price
137.71
▼ 2.25 (1.61%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
139.96
Day high
137.71
Day low
137.71
Volume
100
Market cap
$15.07B
P/E (TTM)
76.51
52W range
74.52 – 210.25
Trailing performance
Returnvs SPY
1W
+10.82%
+12.0%
1M
+26.32%
+23.0%
3M
+61.22%
+58.8%
6M
+63.92%
+52.0%
YTD
-1.13%
-13.1%
1Y
-26.90%
-47.1%
3Y
+219.36%
+144.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on PMCUF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
51.15M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 30, 26 | English (Danny) Chief Financial Officer |
— | 1.43K | — | Direct |
| Jun 30, 26 | Westerhoff (Malte) General Manager |
— | 1.97K | — | Direct |
| Mar 15, 26 | Hatch (Clayton James) Former |
— | 2.00K | — | Direct |
| Feb 26, 26 | Hall (Anthony Barry) Director (Executive) |
BUY | 8.15K | $706.00K | Direct |
| Feb 25, 26 | Hall (Anthony Barry) Director (Executive) |
BUY | 9.00K | $733.45K | Direct |
| Feb 24, 26 | Hall (Anthony Barry) Director (Executive) |
BUY | 8.50K | $660.42K | Direct |
| Feb 24, 26 | Hupert (Sam Aaron) Chief Executive Officer |
BUY | 4.50K | $345.16K | Direct |
| Feb 23, 26 | Kempen (Peter Terence) Non Executive Chairman |
BUY | 400 | $32.85K | Direct |
| Feb 13, 26 | Glenning (Anthony) Independent Non-Executive Director |
BUY | 2.08K | $176.26K | Direct |
| Feb 13, 26 | Shiff (Deena Robyn) Independent Non-Executive Director |
BUY | 788 | $70.60K | Direct |
| Dec 29, 25 | Kempen (Peter Terence) Non Executive Chairman |
BUY | 600 | $149 | Direct |
| Dec 23, 25 | Hall (Anthony Barry) Director (Executive) |
BUY | 2.27K | $335.07K | Direct |
| Dec 23, 25 | Hupert (Sam Aaron) Chief Executive Officer |
BUY | 2.25K | $334.65K | Direct |
| Dec 22, 25 | Hall (Anthony Barry) Director (Executive) |
BUY | 2.25K | $332.27K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Glenning (Anthony) |
Independent Non-Executive Director | 11.65K | Purchase |
Hall (Anthony Barry) |
Director (Executive) | 24.17M | Purchase |
Hatch (Clayton James) |
Former | 28.00K | Other |
Hupert (Sam Aaron) |
Chief Executive Officer | 24.20M | Purchase |
Kempen (Peter Terence) |
Non Executive Chairman | 630.08K | Purchase |
Lambright (Sean) |
Other Executive | 127.59K | Other |
Shiff (Deena Robyn) |
Independent Non-Executive Director | 2.71K | Purchase |
Tauber (Danny) |
General Manager | 164.01K | Other |
Westerhoff (Malte) |
General Manager | 87.10K | Other |
Williams (Alice Joan Morrice) |
Independent Non-Executive Director | 2.19K | Other |
Fundamentals
Market cap$15.07B
Enterprise value$14.79B
Revenue (TTM)$261.69M
Gross profit$261.29M
EBITDA$196.49M
Net income$265.34M
EPS (TTM)$1.80
Free cash flow$98.87M
Total cash$252.28M
Total debt$2.23M
Book value / share$3.07
Shares outstanding104.47M
Float53.00M
Short % of float—
Dividend yield0.34%
Beta (5Y)0.57
Valuation & profitability ratios
Trailing P/E76.51
Forward P/E—
PEG ratio—
Price / sales—
Price / book44.82
EV / revenue56.53
EV / EBITDA75.29
Gross margin99.85%
Operating margin77.02%
Profit margin101.40%
Return on equity74.97%
Return on assets25.84%
Debt / equity0.50
Current ratio6.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $261.62M | $212.91M | $161.43M | $124.79M | — | +22.9% |
| Operating revenue | $261.62M | $212.91M | $161.43M | $124.79M | — | +22.9% |
| Cost of revenue | $401.00K | $309.00K | $301.00K | $544.00K | — | +29.8% |
| Gross profit | $261.21M | $212.60M | $161.13M | $124.24M | — | +22.9% |
| Selling, general & admin | $45.99M | $40.02M | $33.27M | $26.59M | — | +14.9% |
| Total operating expense | $65.17M | $54.98M | $48.95M | $40.48M | — | +18.5% |
| Operating income | $196.04M | $157.61M | $112.18M | $83.76M | — | +24.4% |
| Net interest income | $9.06M | $7.56M | $4.83M | $2.43M | — | +19.9% |
| Pre-tax income | $377.52M | $163.31M | $116.50M | $86.13M | — | +131.2% |
| Tax provision | $112.17M | $48.09M | $33.70M | $25.48M | — | +133.2% |
| Net income | $265.34M | $115.22M | $82.79M | $60.65M | — | +130.3% |
| Net income to common | $265.34M | $115.22M | $82.79M | $60.65M | — | +130.3% |
| Basic EPS | — | 1.10 | 0.79 | 0.58 | 0.43 | — |
| Diluted EPS | — | 1.10 | 0.79 | 0.58 | 0.43 | — |
| EBIT | $196.04M | $157.61M | $112.18M | $83.76M | — | +24.4% |
| EBITDA | $204.10M | $164.85M | $120.69M | $91.69M | — | +23.8% |
| Basic shares | — | 104.48M | 104.44M | 104.41M | 104.31M | — |
| Diluted shares | — | 104.65M | 104.67M | 104.57M | 104.57M | — |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $216.13M | $174.54M | $123.92M | $91.25M | — | +23.8% |
| Cash & short-term investments | $250.62M | $209.19M | $155.43M | $121.50M | — | +19.8% |
| Accounts receivable | $97.55M | $64.07M | $47.91M | $39.65M | — | +52.3% |
| Inventory | — | $98.00K | $49.00K | $55.00K | $77.00K | — |
| Total current assets | $357.97M | $280.09M | $207.10M | $163.79M | — | +27.8% |
| Property, plant & equipment | $2.79M | $2.77M | $2.38M | $2.19M | — | +0.8% |
| Goodwill & intangibles | $22.08M | $20.77M | $20.07M | $21.35M | — | +6.3% |
| Total assets | $610.14M | $338.70M | $257.96M | $202.13M | — | +80.1% |
| Total current liabilities | $52.25M | $43.14M | $34.56M | $30.85M | — | +21.1% |
| Total debt | $2.23M | $2.25M | $2.07M | $1.85M | — | -1.1% |
| Total liabilities | $159.22M | $81.74M | $69.70M | $63.36M | — | +94.8% |
| Retained earnings | $440.02M | $239.46M | $173.36M | $127.12M | — | +83.8% |
| Shareholder equity | $450.92M | $256.96M | $187.73M | $138.78M | — | +75.5% |
| Working capital | $305.72M | $236.96M | $172.54M | $132.94M | — | +29.0% |
| Net tangible assets | $428.83M | $236.20M | $167.66M | $117.43M | — | +81.6% |
| Shares issued | 104.47M | 104.46M | 104.42M | 104.43M | — | +0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$8.69M | -$7.38M | -$6.69M | -$6.45M | -17.7% |
| Investing cash flow | -$12.24M | -$6.58M | -$73.28M | -$7.56M | -86.1% |
| Share buybacks | -$10.14M | -$7.85M | -$2.77M | -$845.00K | -29.1% |
| Dividends paid | -$64.78M | -$49.11M | -$36.55M | -$26.11M | -31.9% |
| Financing cash flow | -$75.55M | -$57.62M | -$39.84M | -$27.53M | -31.1% |
| Free cash flow | $118.80M | $103.95M | $75.29M | $56.09M | +14.3% |
| End cash position | $146.48M | $107.49M | $60.06M | $91.25M | +36.3% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-06-30 | YoY |
|---|---|---|
| Cash & equivalents | $174.54M | |
| Cash & short-term investments | $209.19M | |
| Accounts receivable | $64.07M | |
| Inventory | $98.00K | |
| Total current assets | $280.09M | |
| Property, plant & equipment | $2.77M | |
| Goodwill & intangibles | $20.77M | |
| Total assets | $338.70M | |
| Total current liabilities | $43.14M | |
| Total debt | $2.25M | |
| Total liabilities | $81.74M | |
| Retained earnings | $239.46M | |
| Shareholder equity | $256.96M | |
| Working capital | $236.96M | |
| Net tangible assets | $236.20M | |
| Shares issued | 104.46M |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $338.99M | +29.5% |
| Next year | — | — | $420.31M | +24.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders48.96%
Held by institutions25.19%
Institutions holding262
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
129.99
+5.94% from price
SMA 20
122.81
+17.26% from price
SMA 50
125.94
+14.34% from price
SMA 100
111.19
+23.85% from price
SMA 200
118.73
+21.28% from price
EMA 12
130.78
+5.30% from price
EMA 26
126.69
+8.70% from price
EMA 50
122.71
+12.23% from price
RSI (14)
67.5
Neutral
MACD (12,26,9)
4.09
Hist 2.59
ATR (14)
4.22
2.93% of price
Realised vol 30D
65.6%
Annualised
Bollinger upper
142.96
20, 2σ
Bollinger lower
102.65
20, 2σ
50 / 200 cross
Golden
125.94 vs 118.73
Trend bias
Above 200
+21.28%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.15
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
65.6%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-63.5%
Peak to trough
Max drawdown 5Y
-64.9%
Peak to trough
ATR 14
4.22
2.93% of price
Beta (reported)
0.57
5Y monthly, from filing
Dividends & splits
Forward rate$0.49 / yr
Forward yield0.34%
5-year avg yield0.31%
Payout ratio24.45%
Ex-dividend dateSep 8, 2026
Next pay date—
Last split1002:1000
Split dateMar 12, 2019
Headlines
Pro Medicus Ltd (PMCUF) (FY 2026) Earnings Call Highlights: Record Revenue and Strategic ...
GuruFocus.com · 6d ago
Small Cap Watch: Actinogen hosts Alzheimer’s forum; SEG unveils MediaWorks deal and Pro Medicus wins US contract
Proactive · 13d ago
Visage Highlights One Platform AI-Optimized at SIIM26
PR Newswire · 77d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.